Advertisement

Medical Oncology

, Volume 20, Issue 3, pp 211–220 | Cite as

Relationship between Hodgkin’s and non-Hodgkin’s lymphomas

  • Rose-Marie AminiEmail author
  • Gunilla Enblad
Review

Abstract

Malignant lymphomas have traditionally been classified as either Hodgkin’s (HL) or non-Hodgkin’s lymphomas (NHL). The tumor cells in NHL have been identified as being derived from T- or B-lymphocytes, but not until recently was it possible to identify the origin of the tumor cells in HL. Differential diagnostic problems may exist with morphological overlaps between HL and NHL but do not reflect an underlying biological relationship. Recent observations indicate that HL and NHL may be more closely related than previously believed. HL and NHL may occur sequentially or simultaneously in one and the same individual and in a few cases a clonal relationship between the lymphomas has been proven. It is thus possible that a biological relationship between the disorders may exist in addition to morphological overlaps, and the purpose with this review is to summarize the different relations between HL and NHL.

Key Words

Hodgkin’s lymphoma non-Hodgkin’s lymphoma interrelationship clonality 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Harris, N.L., et al. (1994). A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84:1361–1392.PubMedGoogle Scholar
  2. 2.
    Jaffe, E.S. and Mueller-Hermelink, K. (1999). Relationship between Hodgkin’s disease and non-Hodgkin’s lymphomas, in Hodgkin’s Disease (P.M. Mauch, et al., eds), pp181–193, Lippincott Williams & Wilkins, Philadelphia.Google Scholar
  3. 3.
    Küppers, R., et al. (1994). Hodgkin’s disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc. Natl. Acad. Sci. 91:10,962–10,966.CrossRefGoogle Scholar
  4. 4.
    Kanzler, H., Küppers, R., Hansmann, M.L. and Rajewsky, K. (1996). Hodgkin and Reed-Sternberg cells in Hodgkin’s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184:1495–1504.PubMedCrossRefGoogle Scholar
  5. 5.
    Bennet, M.H., MacLennan, K.A., Vaughan Hudson, G. and Vaughan Hudson, B. (1991). Non-Hodgkin’s lymphoma arising in patients treated for Hodgkin’s disease in the BNLI: a 20 year experience. Ann. Oncol. 2:83–92.Google Scholar
  6. 6.
    Henry-Amar, M. (1992). Second cancer after treatment for Hodgkin’s disease: a report from the international database on Hodgkin’s disease. Ann. Oncol. 3:117–128.PubMedGoogle Scholar
  7. 7.
    Henry-Amar, M. and Joly, F. (1996). Late complications after Hodgkin’s disease. Ann. Oncol. 7:115–126.PubMedGoogle Scholar
  8. 8.
    Rüffer, U., et al. (2001). Non-Hodgkin’s lymphoma after primary Hodgkin’s disease the German Hodgkin’s Lymphoma Study Group: incidence, treatment and prognosis. J. Clin. Oncol. 19(7):2026–2032.Google Scholar
  9. 9.
    Dores, G.M., et al. (2002). Second malignant neoplasms among long-term survivors of Hodgkin’s disease: a population-based evaluation over 25 years. J. Clin. Oncol. 20:3484–3494.PubMedCrossRefGoogle Scholar
  10. 10.
    Travis, L.B., Gonzales, C.L., Hankey, B.F. and Jaffe, E.S. (1992). Hodgkin’s disease following non-Hodgkin’s lymphoma. Cancer 69:2337–2342.PubMedCrossRefGoogle Scholar
  11. 11.
    Jaffe, E.S., Zarate-Osorno, A., Kingma, D.W., Raffeld, M. and Medeiros, L.J. (1994). The interrelationship between Hodgkin’s disease and non-Hodgkin’s lymphoma. Ann. Oncol. 5:7–11.PubMedGoogle Scholar
  12. 12.
    Amini, R.-M., Enblad, G., Sundström, C. and Glimelius, B. (1997). Patients suffering from both Hodgkin’s disease and non-Hodgkin’s lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients. Int. J. Cancer 71:510–516.PubMedCrossRefGoogle Scholar
  13. 13.
    Merk, K., et al. (1990). Epidemiological study of Hodgkin’s disease in Cuba and Sweden. Oncology 47:246–250.PubMedCrossRefGoogle Scholar
  14. 14.
    Hartge, P., Devesa, S.S. and Fraumeni, J.F., Jr. (1994). Hodgkin’s and non-Hodgkin’s lymphomas. Cancer Surv. 19–20:423–453.PubMedGoogle Scholar
  15. 15.
    Foss Abrahamsen, A., et al. (1997). Hodgkin’s disease in a national and hospital population: trends over 20 years. Eur. J. Cancer 33:2380–2383.PubMedCrossRefGoogle Scholar
  16. 16.
    Liu, S., Semenciw, R., Waters, C., Wen, S.W. and Mao, Y. (2000). Time trends and sex patterns in Hodgkin’s disease incidence in Canada, 1970–1995. Can. J. Public Health 91:188–192.PubMedGoogle Scholar
  17. 17.
    Hjalgrim, H., et al. (2001). Incidence of Hodgkin’s disease in Nordic countries. Lancet 358:297–298.PubMedCrossRefGoogle Scholar
  18. 18.
    Seow, A., Lee, J., Sng, I., Fong, C.M. and Lee, H.P. (1996). Non-Hodgkin’s lymphoma in an Asian population: 1968–1992: time trends and ethnic differences in Singapore. Cancer 77:1899–1904.PubMedCrossRefGoogle Scholar
  19. 19.
    Seitz, V., et al. (2000). Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin’s disease. Blood 95:3020–3024.PubMedGoogle Scholar
  20. 20.
    Müschen, M., et al. (1991). Rare occurrence of classical Hodgkin’s disease as a T cell lymphoma. J. Exp. Med. 191:387–394.CrossRefGoogle Scholar
  21. 21.
    Marafioti, T., et al. (2000). Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 95:1443–1450.PubMedGoogle Scholar
  22. 22.
    Stein, H., et al. (2001). Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 97:496–501.PubMedCrossRefGoogle Scholar
  23. 23.
    Lam, K.P., Kuhn, R. and Rajewsky, K. (1997). In vivo ablation of surface immunoglobulin on mature B cells by inducable gene targeting results in rapid cell death. Cell 90:1073–1083.PubMedCrossRefGoogle Scholar
  24. 24.
    Gruss, H.-J., Pinto, A., Duyster, J., Poppema, S. and Herrmann, F. (1997). Hodgkin’s disease: a tumor with disturbed immunological pathways. Immunol. Today 4:156–163.CrossRefGoogle Scholar
  25. 25.
    Kadin, M.E. and Liebowitz, D.N. (1999). Cytokines and cytokine receptors in Hodgkin’s Disease, in Hodgkin’s Disease (Mauch, P.M., et al., eds), pp139–157, Lippincott Williams & Wilkins, Philadelphia.Google Scholar
  26. 26.
    Poppema, S. and van den Berg, A. (2000). Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas. Semin. Cancer Biol. 10:345–350.PubMedCrossRefGoogle Scholar
  27. 27.
    Hsu, P.-L. and Hsu, S.-M. (2000). Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin’s disease and anaplastic large cell lymphoma. Lab. Invest. 80:1111–1119.PubMedGoogle Scholar
  28. 28.
    Kapp, U., et al. (1999). Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J. Exp. Med. 189:1939–1945.PubMedCrossRefGoogle Scholar
  29. 29.
    Bernhards, J., Fischer, R., Hubner, K., Schwarze, E.-W. and Georgii, A. (1992). Histopathological classification of Hodgkin’s lymphoma. Ann. Oncol. 3:31–33.PubMedGoogle Scholar
  30. 30.
    Georgii, A., Fischer, R., Hubner, K., Schwarze, E.W. and Bernhards, J. (1993). Classification of Hodgkin’s disease biopsies by a panel of four histopathologists. Report of 1,140 patients from the German National Trial. Leuk. Lymphoma 9:365–370.PubMedCrossRefGoogle Scholar
  31. 31.
    Rüdiger, T., et al. (1998). Workshop report on Hodgkin’s disease and related diseases (“grey zone” lymphoma). Ann. Oncol. 9:31–38.CrossRefGoogle Scholar
  32. 32.
    Gatter, K.C. and Warnke, R.A. (2001). Diffuse large B-cell lymphoma, in Tumours of Haematopoietic and Lymphoid Tissue. World Health Organization Classification of Tumours (Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds), pp171–174, IARC, Lyon.Google Scholar
  33. 33.
    Banks, P.M. and Warnke, R.A. (2001). Mediastinal (thymic) large B-cell lymphoma, in Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours (Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds), pp175–176, IARC, Lyon.Google Scholar
  34. 34.
    Drexler, H.G., Gignac, S.M., von Wasielewski, R., Werner, M. and Dirks, W.G. (2000). Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia 14:1533–1559.PubMedCrossRefGoogle Scholar
  35. 35.
    Stein, H., et al. (2000). CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96:3681–3695.PubMedGoogle Scholar
  36. 36.
    Delsol, G., Ralfkiaer, E., Stein, H., Wright, D. and Jaffe, E.S. (2001). Anaplastic large cell lymphoma, in Pathology and Genetics of Tumours of Haematopoietic and Lymphoid tissues. World Health Organization Classification of Tumours (Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds), pp230–235, IARC, Lyon.Google Scholar
  37. 37.
    Herling, M., et al. (2001). Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin’s disease: results with ALK-11 antibody in 327 untreated patients. Leuk. Lymphoma 42:969–979.PubMedGoogle Scholar
  38. 38.
    Jaffe, E.S. (2001). Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopahology. Mod. Pathol. 14:219–228.PubMedCrossRefGoogle Scholar
  39. 39.
    Ralfkiaer, E., Müller-Hermelink, H.K. and Jaffe, E.S. (2001). Peripheral T-cell lymphoma, unspecified, in Pathology and Genetics of Tumours of Haematopoietic and Lymphoid tissues. World Health Organization Classification of Tumours (Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds), pp227–229, IARC, Lyon.Google Scholar
  40. 40.
    Davies, T., Morton, C., Miller-Cassman, R., Balk, S. and Kadin, M. (1992). Hodgkin’s disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N. Engl. J. Med. 326:1115–1122.CrossRefGoogle Scholar
  41. 41.
    Brousset, P., et al. (1996). Hodgkin’s disease following mycosis fungoides: phenotypic and molecular evidence for different tumour cell clones. J. Clin. Pathol. 49:504–507.PubMedCrossRefGoogle Scholar
  42. 42.
    Marafioti, T., et al. (1997). Origin of nodular lymphocyte-predominant Hodgkin’s disease from a clonal expansion of highly mutated germinal-center B cells. N. Engl. J. Med. 337:453–458.PubMedCrossRefGoogle Scholar
  43. 43.
    Achten, R., Verhoef, G., Vanuytsel, L. and De Wolf-Peeters, C. (2002). Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology 40:31–45.PubMedCrossRefGoogle Scholar
  44. 44.
    Rüdiger, T., et al. (2002). Workshop on the relationship between nodular lymphocyte predominant Hodgkin’s lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann. Oncol. 13(Suppl. 1):44–51.PubMedGoogle Scholar
  45. 45.
    Jundt, F., et al. (2002). Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. Blood 99(8):3060–3062.PubMedCrossRefGoogle Scholar
  46. 46.
    Brauninger, A., et al. (1999). MOlecular analysis of single B cells from T-cell rich B-cell lymphoma shows the derivation of the tumour cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells. Blood 93:2679–2678.PubMedGoogle Scholar
  47. 47.
    Krikorian, J.G., Burke, J.S., Rosenberg, S.A. and Kaplan, H.S. (1979). Occurrence of non-Hodgkin’s lymphoma after therapy for Hodgkin’s disease. N. Engl. J. Med. 300:452–458.PubMedCrossRefGoogle Scholar
  48. 48.
    Kingma, D.W., et al. (1994). Epstein-Barr virus is infrequently identified in non-Hodgkin’s lymphoma associated with Hodgkin’s disease. Am. J. Surg. Pathol. 18:48–61.PubMedCrossRefGoogle Scholar
  49. 49.
    Carrato, A., Filippa, D. and Koziner, B. (1987). Hodgkin’s disease after treatment of non-Hodgkin’s lymphoma. Cancer 60:887–896.PubMedCrossRefGoogle Scholar
  50. 50.
    Williams, J., Schned, A., Cotelingam, J.D. and Jaffe, E.S. (1991). Chronic lymphocytic leukemia with coexistent Hodgkin’s disease: implications for the origin of the Reed-Sternberg cell. Am. J. Surg. Pathol. 15:33–42.PubMedCrossRefGoogle Scholar
  51. 51.
    Ohno, T., et al. (1998). Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with “Hodgkin’s transformation.” Blood 91:1757–1761.PubMedGoogle Scholar
  52. 52.
    Momose, H., Jaffe, E.S., Shin, S.S., Chen, Y.Y. and Weiss, L.M. (1992). Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg like cells and possible transformation to Hodgkin’s disease: mediation by Epstein-Barr virus. Am. J. Surg. Pathol. 16:859–867.PubMedCrossRefGoogle Scholar
  53. 53.
    Richter, M.N. (1928). Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am. J. Pathol. 4:285–292.PubMedGoogle Scholar
  54. 54.
    O’Sullivan, M.J., Kaleem, Z., Bolger, M.J., Swanson, P.E. and Zutter, M.M. (2000). Composite prolymphocytoid and hodgkin transformation of chronic lymphocytic leukemia. Arch. Pathol. Lab. Med. 124(6):907–909.PubMedGoogle Scholar
  55. 55.
    Giles, F.J., O’Brien, S.M. and Keating, M.J. (1998). Chronic lymphocytic leukemia in (Richter’s) transformation. Semin. Oncol. 25:117.PubMedGoogle Scholar
  56. 56.
    Gonzales, C.L., Medeiros, L.J. and Jaffe, E.S. (1991). Composite lymphoma: a clinicopathologic analysis of nine patients with Hodgkin’s disease and B-cell non-Hodgkin’s lymphoma. Am. J. Clin. Pathol. 96:81–89.Google Scholar
  57. 57.
    van den Bergh, A., et al. (2002). Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma. Blood 100(4):1425–1429.Google Scholar
  58. 58.
    Niedobitek, G., et al. (2000). Hodgkin’s disease and peripheral T-cell lymphoma: composite lymphoma with evidence of Epstein-Barr virus infection. J. Pathol. 191(4):394–399.PubMedCrossRefGoogle Scholar
  59. 59.
    Wlodarska, I., et al. (1993). T-Cell lymphoma developing in Hodgkin’s disease: evidence for two clones. J. Pathol. 170:239–248.PubMedCrossRefGoogle Scholar
  60. 60.
    Kremer, M., et al. (2001). Epstein-Barr virus-negative Hodgkin’s lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin. Mod. Pathol. 14:91–97.PubMedCrossRefGoogle Scholar
  61. 61.
    Hawkins, K.A., et al. (1983). Simultaneous occurrence of mycosis fungoides and Hodgkin’s disease: clinical and histologic correlations in three cases with ultrastructural studies in two. Am. J. Hematol. 14:355–362.PubMedCrossRefGoogle Scholar
  62. 62.
    Bee, C.S., Blaise, Y.P. and Dunphy, C.H. Composite lymphoma of Hodgkin lymphoma and mycosis fungoides: previously underscribed in the same extracutaneous site. Leuk. Lymphoma 42:543–549.Google Scholar
  63. 63.
    Greene, M.H., et al. (1982). Lymphomas and leukemias in the relatives of patients with mycosis fungoides. Cancer 49:737–741.PubMedCrossRefGoogle Scholar
  64. 64.
    Brauninger, A., et al. (1999). Identification of common germinal-center B-cell precursors in two patients with both Hodgkin’s disease and non-Hodgkin’s lymphoma. N. Engl. J. Med. 340:1239–1247.PubMedCrossRefGoogle Scholar
  65. 65.
    Küppers, R., et al. (2001). Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin’s disease and either follicular lymphoma or B-CLL. Mol. Med. 7:285–292.PubMedGoogle Scholar
  66. 66.
    Barrios, L., et al. (1988). Chromosomal abnormalities in peripheral blood lymphocytes from untreated Hodgkin’s patients. A possible evidence for genetic instability. Hum. Genet. 78:320–324.PubMedCrossRefGoogle Scholar
  67. 67.
    M’kacher, R., et al. (2001). Treatment induced chromocomal aberrations in circulating lymphocytes in patients with Hodgkin’s disease. Leuk. Lymphoma 42:35 (abstract).Google Scholar
  68. 68.
    Müller-Hermelink, H.K., Zettl, A., Pfeifer, W. and Ott, G. (2001). Pathology of lymphoma progression. Histopathology 38:285–306.PubMedCrossRefGoogle Scholar
  69. 69.
    Amini, R.-M., et al. (2002). A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma. Leuk. Lymphoma 43:2179–2189.PubMedCrossRefGoogle Scholar
  70. 70.
    Cazals-Hatem, D., et al. (2001). Pathologic and clinical features of 77 Hodgkin’s lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study. Am. J. Surg. Pathol. 25:297–306.PubMedCrossRefGoogle Scholar
  71. 71.
    Enblad, G., Gustafsson, A., Sundström, C. and Glimelius, B. (2002). Elderly patients with Hodgkin lymphoma treated with a new treatment strategy. Acta Oncolo., in press.Google Scholar

Copyright information

© Humana Press Inc 2003

Authors and Affiliations

  1. 1.Department of Oncology, Radiology and Clinical ImmunologyUppsala University, Uppsala University HospitalUppsalaSweden
  2. 2.Department of Genetics and PathologyUppsala University, Uppsala University HospitalUppsalaSweden

Personalised recommendations